Pacific Biosciences Of California (PACB) Other Accumulated Expenses (2011 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Other Accumulated Expenses of $1.2 million for Q1 2026, down 77.83% year-over-year from $5.6 million in Q1 2025, and down 39.19% quarter-over-quarter from $2.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 77.83% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 77.83% YoY), while the FY2025 annual figure was $2.0 million, down 37.0% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $1.2 million, down from $2.0 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $8.3 million in Q4 2023, with the low at $783000.0 in Q3 2024.
- The 5-year median for Other Accumulated Expenses is $4.6 million (2022), against an average of $4.3 million.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses soared 351.78% in 2022, then tumbled 84.85% in 2024.
- Pacific Biosciences Of California's Other Accumulated Expenses stood at $7.2 million in 2022, then rose by 15.11% to $8.3 million in 2023, then sank by 61.28% to $3.2 million in 2024, then sank by 37.0% to $2.0 million in 2025, then tumbled by 39.19% to $1.2 million in 2026.
- Business Quant data shows PACB's Other Accumulated Expenses at $1.2 million in Q1 2026, $2.0 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 2.59 Mn |
| Mar 31, 2025 | 5.57 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 783,000.00 |
| Jun 30, 2024 | 6.75 Mn |
| Mar 31, 2024 | 2.84 Mn |
| Dec 31, 2023 | 8.33 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 7.23 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Jun 30, 2022 | 5.91 Mn |
| Mar 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Jun 30, 2021 | 3.59 Mn |